The Effect of Su-Jok Application and Progressive Muscle Relaxation Exercises in Coping With Premenstrual Syndrome

March 29, 2024 updated by: Saglik Bilimleri Universitesi
The aim of this study is to determine the effect of su-jok application and progressive muscle relaxation exercise in coping with premenstrual syndrome.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Various medications can be used to relieve PMS symptoms, but there is no treatment to completely eliminate it. For this reason, women may seek traditional and alternative practices to reduce PMS complaints. Alternative methods such as herbal treatment, aromatherapy, acupuncture, nutrition regulation and stress control can be used to relieve PMS symptoms. It has been stated that applying mind-body based therapies to relieve PMS symptoms is safe and cost-effective. Such interventions include progressive muscle relaxation exercise (PCGE), paced breathing, clinical hypnosis, yoga, mindfulness, reflexology, and cognitive behavioral therapies. Su-Jok application, which is an alternative method, can also be used to relieve PMS symptoms. In Su-Jok therapy, the practitioner stimulates points on the hands and feet to activate auto-regulatory mechanisms and bring the body to a healthy state. Due to the negative effects of PMS on daily life, knowing the frequency of occurrence and risk factors is expected to contribute and guide individuals in coping with PMS. While PMS threatens the health of the individual in particular, it generally brings socio-economic burdens to the individual, family and society.

Study Type

Interventional

Enrollment (Estimated)

135

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Getting over 104 points from the PMS scale,
  • Having regular menstruation,
  • Not having any chronic disease,
  • Not using any method to cope with PMS.

Exclusion Criteria:

  • Having irregular menstruation,
  • Having musculoskeletal system and respiratory diseases,
  • Having a diagnosed psychiatric disease,
  • Having a disease that may cause premenstrual symptoms and receiving medical treatment (thyroid diseases, heart failure, neurological disorders)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
No application will be made to this group by the researcher.
Experimental: Progressive Muscle Relaxation Exercise Group
Application will be made on the day PMS symptoms begin and throughout the menstrual cycle.
Procedure: Progressive Muscle Relaxation Exercise Group
Exercise Group
Experimental: Su-Jok Group
Application will be made on the day PMS symptoms begin and throughout the menstrual cycle.
Procedure: Su-Jok Intervention
Hand massage with seeds

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PAIN Visual Analog Scale (VAS)- (Min:0 - Max:10)
Time Frame: 3 months

In the 1st, 2nd and 3rd month menstrual periods;

  • Premenstrual Syndrome Scale
  • VAS evaluation scale will be applied.
3 months
FATIGUE Visual Analog Scale (VAS)- (Min:0 - Max:10)
Time Frame: 3 months

In the 1st, 2nd and 3rd month menstrual periods;

  • Premenstrual Syndrome Scale
  • VAS evaluation scale will be applied.
3 months
SLEEP STATE Visual Analog Scale (VAS)- (Min:0 - Max:10)
Time Frame: 3 months

In the 1st, 2nd and 3rd month menstrual periods;

  • Premenstrual Syndrome Scale
  • VAS evaluation scale will be applied.
3 months
NAUSEA VOMITING Visual Analog Scale (VAS)- (Min:0 - Max:10)
Time Frame: 3 months

In the 1st, 2nd and 3rd month menstrual periods;

  • Premenstrual Syndrome Scale
  • VAS evaluation scale will be applied.
3 months
Change in Premenstrual Symptoms (People with PMS scale scores over 104 points will be determined).
Time Frame: 3 months

In the 1st, 2nd and 3rd month menstrual periods;

  • Premenstrual Syndrome Scale
  • VAS evaluation scale will be applied.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Saglik Bilimleri Universitesi

Investigators

  • Principal Investigator: Filiz Ünal Toprak, PhD, Saglik Bilimleri Universitesi
  • Principal Investigator: Sevil Albayrak, PhD, Cyprus Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 10, 2024

Primary Completion (Estimated)

July 15, 2024

Study Completion (Estimated)

August 15, 2024

Study Registration Dates

First Submitted

February 12, 2024

First Submitted That Met QC Criteria

February 28, 2024

First Posted (Actual)

March 6, 2024

Study Record Updates

Last Update Posted (Actual)

April 1, 2024

Last Update Submitted That Met QC Criteria

March 29, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SBU-FUT-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premenstrual Syndrome

Clinical Trials on Progressive Muscle Relaxation Exercise Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe